Internal Medicine, Pulmonary Disease · Peoria, AZ
NPI
1437122397
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
13634 N 93rd Ave Ste 100
Peoria, AZ, 85381
Phone (623) 933-0301
Groups this clinician bills Medicare through
Medicare paid, 2024
$183K
2,287 services
Medicare patients, 2024
524
Average age 76
Drug cost, 2024
$1.7M
3,571 prescriptions
Company payments, 2025
$1,094
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit Dhingra was code 99233 (hospital e&m - subsequent), 413 times for 112 patients. In total Amit Dhingra billed 2,287 services in 36 codes, and Medicare paid $183K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 413 | 112 | $94.44 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 401 | 248 | $12.91 | $5,177 |
| 99214 Office E&M - Established | Office | 255 | 183 | $96.43 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 245 | 107 | $62.70 | $15K |
| 99215 Office E&M - Established | Office | 243 | 143 | $134.73 | $33K |
| 99291 Critical Care E&M | Facility | 112 | 32 | $165.03 | $18K |
| 99223 Hospital E&M - Initial | Facility | 83 | 74 | $131.56 | $11K |
| 99222 Hospital E&M - Initial | Facility | 74 | 73 | $96.82 | $7,165 |
| 94729 Pulmonary Function Testing | Office | 74 | 74 | $44.82 | $3,316 |
| 94060 Pulmonary Function Testing | Office | 73 | 73 | $30.87 | $2,254 |
| 94726 Pulmonary Function Testing | Office | 73 | 73 | $44.91 | $3,278 |
| 99204 Office E&M - New | Office | 54 | 54 | $125.97 | $6,802 |
| 99205 Office E&M - New | Office | 28 | 28 | $150.06 | $4,202 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 24 | 22 | $26.76 | $642 |
| 94664 E&M - Miscellaneous | Office | 21 | 21 | $14.38 | $302 |
By year: 2022 $139K for 1,483 services; 2023 $166K for 1,872 services; 2024 $183K for 2,287 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit Dhingra prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 546 prescriptions and refills. In total Amit Dhingra wrote 3,571 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 546 | 635 | 234 | $15K |
| Advair Hfa Fluticasone Propion/Salmeterol | 347 | 404 | 77 | $132K |
| Montelukast Sodium Generic | 251 | 488 | 79 | $2,884 |
| Breo Ellipta Fluticasone/Vilanterol | 247 | 307 | 48 | $118K |
| Symbicort Budesonide/Formoterol Fumarate | 208 | 273 | 76 | $61K |
| Spiriva Respimat Tiotropium Bromide | 200 | 265 | 39 | $137K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 196 | 301 | 59 | $41K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 164 | 202 | 31 | $125K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 143 | 175 | 25 | $83K |
| Incruse Ellipta Umeclidinium Bromide | 139 | 165 | 25 | $55K |
| Prednisone Generic | 105 | 107 | 71 | $366 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 104 | 120 | 28 | $73K |
| Arnuity Ellipta Fluticasone Furoate | 95 | 113 | 21 | $23K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 81 | 93 | 16 | $7,044 |
| Breyna Budesonide/Formoterol Fumarate | 68 | 81 | 27 | $13K |
Brand drugs: 2,339 claims; generic drugs: 1,232 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit Dhingra $1,094 ($1,094 in general payments such as food, travel and fees) from 18 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $143.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $143 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $141 |
| Baxter Healthcare BAX | 5 | $128 |
| Genzyme Corporation SNY | 3 | $87.49 |
| United Therapeutics Corporation UTHR | 3 | $81.07 |
| Grifols USA, LLC | 2 | $69.53 |
| GlaxoSmithKline, LLC. GSK | 3 | $66.49 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $61.89 |
| Verona Pharma, Inc. VRNA | 2 | $56.55 |
| Pharming Healthcare, Inc. | 2 | $49.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.